FDA Approves At-Home Cervical Cancer Screening with Teal Wand
Teal Health's Teal Wand, approved by the FDA, allows home testing for HPV to improve cervical cancer screening access.
Summary
Teal Health’s Teal Wand is now FDA-approved for at-home cervical cancer screening, enabling women to self-collect samples for HPV testing. Set to launch in California in June, this prescription device addresses the barriers of traditional Pap smears, enhancing comfort and accessibility. The FDA’s approval follows a study confirming the device's efficacy on par with clinical methods. With over 11,500 cervical cancer diagnoses yearly in the US, the test aims to increase screening rates among women, particularly those hesitant to seek in-clinic evaluations. Teal Health is working on insurance coverage plans and expects to expand beyond California soon.
Sources (8)
- At-home cervical cancer screening reduces barriers for women, letting them avoid uncomfortable in-office procedures like Pap smears.
- The FDA's approval of the Teal Wand is expected to increase screening rates, particularly among those who have never been screened or have not done so recently.
- The approval supports efforts to mitigate cervical cancer risk and improve women's health outcomes, emphasizing the importance of HPV vaccination and regular screenings.
The Guardian·12d· "…The approval is not just about an innovative new product, it’s about finally giving women an option that makes sense for their lives, something that can be done quickly and comfortably at home."
CNN·12d· "…The newly approved at-home screening device could be an important tool in getting more women regularly screened, especially those that don’t have access to a medical provider."
FAQ
No FAQs available for this story.
History
- 12d